CSPC PHARMACEUT.GR. ADR4 (CVGU) — Capital Reinvestment Ratio
Latest as of December 2025:
0.39x
CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Capital Reinvestment Ratio of 0.39x as of December 2025, meaning it reinvests 0% of its operating cash flow (€5.83 Billion) in capital expenditures (€2.28 Billion). See CSPC PHARMACEUT.GR. ADR4 (CVGU) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.39x
Capex / Operating Cash Flow
Operating Cash Flow
€5.83 Billion
EUR
Capital Expenditures
€2.28 Billion
EUR
Data as of
Dec 2025
Most recent filing
CSPC PHARMACEUT.GR. ADR4 Capital Reinvestment Ratio (2021–2025)
This chart tracks CSPC PHARMACEUT.GR. ADR4's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Year-by-year Capital Reinvestment Ratio for CSPC PHARMACEUT.GR. ADR4 from 2021 to 2025. For live market cap and broader valuation context, see CSPC PHARMACEUT.GR. ADR4 (CVGU) total market value.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | €5.83 Billion | €2.28 Billion | ▼ -33.8% |
| 2024 | 0.59x | €4.53 Billion | €2.68 Billion | ▲ +30.4% |
| 2023 | 0.45x | €4.18 Billion | €1.89 Billion | ▲ +26.9% |
| 2022 | 0.36x | €7.63 Billion | €2.72 Billion | ▼ -5.9% |
| 2021 | 0.38x | €4.64 Billion | €1.76 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow